Publication | Closed Access
Fisetin alleviates chronic urticaria by inhibiting mast cell activation via MRGPRX2
10
Citations
18
References
2023
Year
Fisetin alleviates CU progression by inhibiting mast cell activation via MRGPRX2, which may be a novel therapeutic candidate for CU.
| Year | Citations | |
|---|---|---|
Page 1
Page 1